New Data for Sacituzumab Govitecan-hziy in the Treatment of Metastatic Triple-Negative Breast Cancer

被引：0
作者：
Bardia, Aditya [1 ,2 ]
机构：
[1] Breast Canc Res Program, Boston, MA 02115 USA
[2] Harvard Med Sch, Med Oncol, Massachusetts Gen Hosp, Boston, MA 02115 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2021年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：723 / 725
页数：3
相关论文
共 50 条
[31]   Considerable Improvement in Overall Survival through Sacituzumab-Govitecan in metastatic triple-negative Breast Cancer [J].
Pervan, Mascha ;
Krawczyk, Natalia ;
Hanker, Lars ;
Bundgen, Nana ;
Rody, Achim ;
Banys-Paluchowski, M. .
ONKOLOGE, 2021, 27 (11) :1131-1136
[32]   Cost-effectiveness of sacituzumab govitecan versus chemotherapy in advanced or metastatic triple-negative breast cancer [J].
Lang, Yitian ;
Chai, Qingqing ;
Tao, Wenqi ;
Liao, Yahui ;
Liu, Xiaoyan ;
Wu, Bin .
BREAST, 2023, 68 :173-180
[33]   Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine [J].
Khan, Saif ;
Jandrajupalli, Suresh Babu ;
Bushara, Nashwa Zaki Ali ;
Raja, Rama Devi Patel ;
Mirza, Shadab ;
Sharma, Kuldeep ;
Verma, Rajan ;
Kumar, Ashish ;
Lohani, Mohtashim .
CELLS, 2024, 13 (24)
[34]   COST-EFFECTIVENESS ANALYSIS OF SACITUZUMAB GOVITECAN AS SECOND-LINE TREATMENT FOR METASTATIC TRIPLE-NEGATIVE BREAST CANCER IN JAPAN [J].
Yamaguchi, M. ;
Maeda, T. ;
Morimoto, K. ;
Chen, W. ;
Moriwaki, K. ;
Shimozuma, K. .
VALUE IN HEALTH, 2023, 26 (06) :S106-S106
[35]   Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis [J].
Lisa A. Carey ;
Delphine Loirat ;
Kevin Punie ;
Aditya Bardia ;
Véronique Diéras ;
Florence Dalenc ;
Jennifer R. Diamond ;
Christel Fontaine ;
Grace Wang ;
Hope S. Rugo ;
Sara A. Hurvitz ;
Kevin Kalinsky ;
Joyce O’Shaughnessy ;
Sibylle Loibl ;
Luca Gianni ;
Martine Piccart ;
Yanni Zhu ;
Rosemary Delaney ;
See Phan ;
Javier Cortés .
npj Breast Cancer, 8
[36]   Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer [J].
Hurvitz, Sara A. ;
Bardia, Aditya ;
Punie, Kevin ;
Kalinsky, Kevin ;
Carey, Lisa A. ;
Rugo, Hope S. ;
Dieras, Veronique ;
Phan, See ;
Delaney, Rosemary ;
Zhu, Yanni ;
Tolaney, Sara M. .
NPJ BREAST CANCER, 2024, 10 (01)
[37]   Exposure-Response Analyses of Sacituzumab Govitecan Efficacy and Safety in Patients With Metastatic Triple-Negative Breast Cancer [J].
Sathe, Abhishek G. ;
Diderichsen, Paul M. ;
Fauchet, Floris ;
Phan, See-Chun ;
Girish, Sandhya ;
Othman, Ahmed A. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (02) :570-578
[38]   Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer [J].
Rugo, Hope S. ;
Tolaney, Sara M. ;
Loirat, Delphine ;
Punie, Kevin ;
Bardia, Aditya ;
Hurvitz, Sara A. ;
O'Shaughnessy, Joyce ;
Cortes, Javier ;
Dieras, Veronique ;
Carey, Lisa A. ;
Gianni, Luca ;
Piccart, Martine J. ;
Loibl, Sibylle ;
Goldenberg, David M. ;
Hong, Quan ;
Olivo, Martin ;
Itri, Loretta M. ;
Kalinsky, Kevin .
NPJ BREAST CANCER, 2022, 8 (01)
[39]   Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer [J].
O'Shaughnessy, Joyce ;
Brufsky, Adam ;
Rugo, Hope S. ;
Tolaney, Sara M. ;
Punie, Kevin ;
Sardesai, Sagar ;
Hamilton, Erika ;
Loirat, Delphine ;
Traina, Tiffany ;
Leon-Ferre, Roberto ;
Hurvitz, Sara A. ;
Kalinsky, Kevin ;
Bardia, Aditya ;
Henry, Stephanie ;
Mayer, Ingrid ;
Zhu, Yanni ;
Phan, See ;
Cortes, Javier .
BREAST CANCER RESEARCH AND TREATMENT, 2022, 195 (02) :127-139
[40]   Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer [J].
Joyce O’Shaughnessy ;
Adam Brufsky ;
Hope S. Rugo ;
Sara M. Tolaney ;
Kevin Punie ;
Sagar Sardesai ;
Erika Hamilton ;
Delphine Loirat ;
Tiffany Traina ;
Roberto Leon-Ferre ;
Sara A. Hurvitz ;
Kevin Kalinsky ;
Aditya Bardia ;
Stephanie Henry ;
Ingrid Mayer ;
Yanni Zhu ;
See Phan ;
Javier Cortés .
Breast Cancer Research and Treatment, 2022, 195 :127-139
12345